Clinical Trial Update: One Fraction Simulation-Free Treatment With CT-Guided Stereotactic Adaptive Radiotherapy for Patients With Oligometastatic and Primary Lung Tumors [Phase 2]

View source ↗

Summary

Clinical trial update on completion of a Phase 2 study evaluating one-fraction simulation-free CT-guided stereotactic adaptive radiotherapy for primary lung tum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Oligometastatic Cancer

Snippet

Sponsor: Washington University School of Medicine | Conditions: Lung Cancer, Oligometastatic Lung Tumor | Phase 2 | Status: COMPLETED